Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

Update: 2022-02-07

Description

In this podcast, Dr. Truchetet discusses her work on the role of innate lymphoid cells in the fibrotic processes in systemic sclerosis (SSc) patients. The group of Dr. Truchetet found that ILC2 are crucial mediators of skin fibrosis in SSc and that combined treatment of patients with TGFb inhibitors and IL-10 might be an attractive new therapeutic approach in SSc.
Read the full paper on the ARD website: https://ard.bmj.com/content/80/12/1594

Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page (https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059).

Comments

In Channel

Use of imaging in large vessel vasculitis: EULAR 2023 update

2024-06-2131:43

Managing Systemic Lupus Erythematosus: the latest EULAR recommendations

2024-04-2221:25

A non-pharma approach in systemic lupus erythematosus and systemic sclerosis

2023-10-3018:55

Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

2022-02-0721:41

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

2021-07-2920:37

The EULAR COVID-19 database and its insights into risk factors

2021-03-1825:43

Predictors of disease worsening in systemic sclerosis

2020-09-1511:34

Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab

2020-08-0623:52

The dose dependent effect of statins on osteoporosis

2020-04-2212:06

A prediction score for individuals at risk to develop rheumatoid arthritis

2020-03-2512:06

Prediction of radiographic progression using synovitis characteristics

2020-03-0610:15

Six-week treatment with low-dose prednisolone in patients with painful hand osteoarthritis

2020-02-1803:08

Highlights from ACR: guselkumab, ixekizumab and secukinumab in SpA

2020-01-2314:56

TULIP 2: Efficacy and Safety of Anifrolumab in Patients

2019-12-2303:52

TULIP 1 - highlights from the ACR meeting

2019-12-1004:51

Capture Hi-C reveals novel drug targets in rheumatic diseases

2019-08-2214:03

EULAR recommendations for the management of systemic lupus erythematosus

2019-07-1210:05

Musculoskeletal diseases on the rise worldwide and affecting developed countries the most

2019-06-0313:18

Three tips to get your manuscript published by ARD

2018-08-2904:40

Early inflammatory arthritis outcomes: what changed in the new millennium?

2018-07-1009:58

00:00

Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

#box-pro-ellipsis-176048202198367{-webkit-line-clamp:2;}Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

BMJ Group

Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin